Eric D. Achtyes, MD, MS

Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan

  • 8Articles
  • 35.8KReads
  • 2016–2025Active
  • 32Collaborators
  • 112Citations

About

Eric D. Achtyes, MD, MS, is affiliated with the Department of Psychiatry at Western Michigan University Homer Stryker M.D. School of Medicine in Kalamazoo, Michigan. From 2016 to 2025, Achtyes has published extensively on topics including schizophrenia, schizoaffective disorders, bipolar disorder, major depressive disorder, electroconvulsive therapy, psychiatry, COVID-19, and weight management. His work addresses clinical applications of aripiprazole long-acting injectables, treatment optimization, telehealth implementation during the COVID-19 pandemic, and cardiovascular risk in patients with serious mental illness. Frequent collaborators include Christoph U. Correll, Joseph F. Goldberg, Martha Sajatovic, Stephen R. Saklad, and A. Eden Evins.

Publications

PCC
Predictors of Depression Response in a Community ECT Clinic
Original Research

Predictors of Depression Response in a Community ECT Clinic

August 28, 2025

Anxiety symptoms may be a factor correlated with depression treatment response, suggesting potential utility in screening for anxiety symptoms in assessing likelihood of success with ECT treatment.
, , , et al
JCP
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
Academic Highlights

Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report

August 13, 2025

A consensus panel reviews treatment considerations in the use of long-acting injectable aripiprazole monohydrate in bipolar type I disorder.
, , , et al
JCP
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report
Academic Highlights

Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report

August 13, 2025

A consensus panel reviews treatment considerations in the use of long-acting injectable aripiprazole monohydrate in schizophrenia.
, , , et al
JCP
Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report
Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

June 13, 2025

A consensus panel reviews the pharmacokinetic advantages and clinical utility of long-acting injectable aripiprazole monohydrate to optimize treatment for schizophrenia and bipolar I disorder.
, , , et al
PCC
PCP Comfort in Treating Psychiatric Patients
Original Research

PCP Comfort in Treating Psychiatric Patients

February 3, 2022

Primary care has become the de facto mental health care system for many patients, yet primary care provider (PCP) comfort level in treating mental disorders is largely unknown. This...
, , , et al
PCC
Brief Report

Transition to Telehealth During the COVID-19 Pandemic

October 1, 2020

This report describes the rapid transition from in-person to telehealth interventions in a community mental health service in Michigan in response to the COVID-19 pandemic. Read on to find...
, , , et al
JCP
Original Research

Early Phase Schizophrenia and LAI

April 23, 2019

Read a study examining if patients in the early phase of schizophrenia would accept LAI antipsychotic treatment.
, , , et al
JCP
Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

March 23, 2016

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe